For the Inventor, By the Inventor

Enter assignee name

Novato, CA, United States of America

Raptor Pharmaceuticals Inc.

USPTO Granted Patents = 12

CIPO Patents = 2

EPO Patents = 2

Trademarks = 1

Forward Citations = 84

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Christopher M Starr (5 out of 19 patents)

Todd C Zankel (5 out of 16 patents)

Kathlene Powell (3 out of 4 patents)

4. Ramesh Muttavarapu (3 out of 4 patents)

5. Thomas E Daley (2 out of 3 patents)

6. Michael N Dudley (1 out of 35 patents)

7. Mark William Surber (1 out of 37 patents)

8. Olga Rodny (1 out of 27 patents)

9. David C Griffith (1 out of 35 patents)

10. Michel Demeule (1 out of 21 patents)

11. Keith A Bostian (1 out of 17 patents)

12. Elizabeth C Squiers (1 out of 5 patents)

13. Kin-Hung Peony Yu (1 out of 1 patent)

14. Kathy Powell (1 out of 1 patent)

15. Olga Jarzebinski (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 9435785 - Methods for analyzing cysteamine compositions (2016-09-06),

2. 9326971 - 4-methylpyrazole formulations for inhibiting ethanol intolerance (2016-05-03),

3. 9326936 - Aerosol fluoroquinolone formulations for improved pharmacokinetics (2016-05-03),

4. 9233077 - Delayed release cysteamine bead formulation, and methods of making and using same (2016-01-12),

5. 9173851 - Delayed release cysteamine bead formulation, and methods of making and using same (2015-11-03),

6. 9173850 - 4-methylpyrazole formulations (2015-11-03),

7. 9062126 - Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof (2015-06-23),

8. 8795627 - Treatment of liver disorders by administration of RAP conjugates (2014-08-05),

9. 8609103 - Megalin-based delivery of therapeutic compounds to the brain and other tissues (2013-12-17),

10. 8440629 - Cyclic receptor-associated protein (RAP) peptides (2013-05-14),

11. 7829537 - Receptor associated protein (RAP) conjugates (2010-11-09),

12. 7700554 - Compositions for modulating blood-brain barrier transport (2010-04-20),

Raptor Pharmaceuticals Inc. is a leading biopharmaceutical company specializing in the development and commercialization of therapeutics for rare diseases. With a focus on life-threatening and debilitating conditions, Raptor strives to make a meaningful impact on the lives of patients by providing innovative and effective treatments. Through dedicated research and development, Raptor aims to address unmet medical needs and improve patient outcomes. For more information about Raptor Pharmaceuticals Inc., please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#7 in Novato, CA

#5,885 in California

#24,831 in US

#46,738 in the World

Novato, CA, United States of America

Raptor Pharmaceuticals Inc.

Forward Citations = 84

19 inventors:

Christopher M Starr (5 out of 19 patents)

Todd C Zankel (5 out of 16 patents)

Kathlene Powell (3 out of 4 patents)

4. Ramesh Muttavarapu (3 out of 4 patents)

5. Thomas E Daley (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…